» Articles » PMID: 10854857

Shedding and Cleavage of the Urokinase Receptor (uPAR): Identification and Characterisation of UPAR Fragments in Vitro and in Vivo

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2000 Jun 16
PMID 10854857
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Applying a novel, highly specific and sensitive immunoabsorption/Western blotting technique we have identified in vitro in conditioned cell culture medium and in vivo in human urine different soluble forms of the urokinase-type plasminogen activator receptor (uPAR/CD87). These include the uPAR fragment D2D3 and the never before identified domain 1 (D1) fragment. These forms correspond to fragments previously characterised as biologically active as inducers of chemotaxis and cell adhesion. We find that stimulation of U937 cells is associated with increased uPAR expression, cleavage of surface uPAR, and release of soluble fragments to the culture medium suggesting that monocytes are a source of the circulating and urinary soluble uPAR fragments found in vivo. Our study demonstrates that potentially biologically active uPAR fragments are produced in the human body, indicating a possible function in the regulation of not only proteolysis but also signal transduction related processes.

Citing Articles

Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity.

Portelli M, Bhaker S, Pang V, Bates D, Johnson S, Mazar A Clin Transl Allergy. 2023; 13(10):e12293.

PMID: 37876037 PMC: 10542610. DOI: 10.1002/clt2.12293.


Detection of soluble urokinase type plasminogen activator receptors in children with gingivitis and normal subjects.

El-Patal M, Khalil M, Shipl W, Barakat I, Youssef E, El Attar S BMC Oral Health. 2022; 22(1):436.

PMID: 36192745 PMC: 9531525. DOI: 10.1186/s12903-022-02478-7.


Melanoma Mediated Disruption of Brain Endothelial Barrier Integrity Is Not Prevented by the Inhibition of Matrix Metalloproteinases and Proteases.

Anchan A, Finlay G, Angel C, Hucklesby J, Graham S Biosensors (Basel). 2022; 12(8).

PMID: 36005056 PMC: 9405625. DOI: 10.3390/bios12080660.


suPAR: An Inflammatory Mediator for Kidneys.

Sudhini Y, Wei C, Reiser J Kidney Dis (Basel). 2022; 8(4):265-274.

PMID: 35949208 PMC: 9251480. DOI: 10.1159/000524965.


suPAR to Risk-Stratify Patients With Malaria.

Stefanova V, Crowley V, Weckman A, Kain K Front Immunol. 2022; 13:931321.

PMID: 35757694 PMC: 9226448. DOI: 10.3389/fimmu.2022.931321.